Oxymetazoline Therapeutic Compositions Stabilized for Long-Term Storage

USPTO issued patent US12605363B2 to RVL Pharmaceuticals, Inc. covering compositions comprising oxymetazoline and methods of stabilizing oxymetazoline compositions for long-term storage. The patent includes 20 claims across classifications including A61K 31/4164, A61K 9/0048, A61K 47/02, A61K 47/12, A61K 47/38, A61P 27/02, and A61F 9/0008. Patent grants establish exclusive rights and do not impose direct compliance obligations on other parties. Pharmaceutical manufacturers developing oxymetazoline-based products should review the patent claims to assess potential licensing needs or design-around considerations.